Form 8-K - Current report:
SEC Accession No. 0001193125-25-020142
Filing Date
2025-02-04
Accepted
2025-02-04 17:29:04
Documents
13
Period of Report
2025-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d826522d8k.htm   iXBRL 8-K 20906
  Complete submission text file 0001193125-25-020142.txt   141580

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA etnb-20250131.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20250131_lab.xml EX-101.LAB 17993
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20250131_pre.xml EX-101.PRE 11256
15 EXTRACTED XBRL INSTANCE DOCUMENT d826522d8k_htm.xml XML 3627
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 25589733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)